Adults 18 to 65, any sex, with Overweight and Obesity or Physical Inactivity. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Acceptability of Move Program Components, Measured With the Acceptability of Intervention Measure (AIM)Primary· 12 weeks
Scores from the Acceptability of Intervention Measure (AIM) range from 1 to 5, with higher scores indicating higher acceptability.
Group-based classes
Group
Value
95% CI
Community Members
4.14
3.66 – 4.62
Coach
5
1:1 support sessions
Group
Value
95% CI
Community Members
4.28
3.70 – 4.86
Coach
5
Guided imagery sessions
Group
Value
95% CI
Community Members
3.25
2.22 – 4.28
Coach
4
Online fitness membership
Group
Value
95% CI
Community Members
4.44
3.61 – 5.28
Coach
5
Feasibility of Move Program Components, Measured With the Feasibility of Intervention Measure (FIM)Primary· 12 weeks
Scores from the Feasibility of Intervention Measure (AIM) range from 1 to 5, with higher scores indicating higher acceptability.
Group-based classes
Group
Value
95% CI
Community Member
4.00
3.60 – 4.40
Coach
5
1:1 support sessions
Group
Value
95% CI
Community Member
4.08
3.61 – 4.55
Coach
4.25
Guided imagery sessions
Group
Value
95% CI
Community Member
3.81
2.82 – 4.79
Coach
4
Online fitness membership
Group
Value
95% CI
Community Member
4.03
2.73 – 5.32
Coach
1.25
Acceptability of the Move Physical Activity Support Program, Measured With the Net Promoter Score (NPS)Primary· 12 weeks
Acceptability of the Move physical activity support program will be assessed using the Net Promoter Score (NPS) from the participant and provider perspectives. The score is calculated as a composite score from responders. Each responder rates the program between 0 and 10. Each responder is categorized as promotors (scores 9-10), passives (scores 7-8), or detractors (scores 0-6). The NPS is then calculated by the \[% of promoters (scores 9 or 10) minus % detractors (scores 6 or lower)\] multiplied by 100. Possible scores ranges from -100 to +100. Scores \>0 indicate the component is acceptable.
Group-based Class Component
Group
Value
95% CI
Community Member
11
Coach
100
1:1 support sessions
Group
Value
95% CI
Community Member
22
Coach
100
Guided imagery sessions
Group
Value
95% CI
Community Member
-22
Coach
0
Online fitness membership
Group
Value
95% CI
Community Member
56
Coach
0
Feasibility of the Move Physical Activity Support Program - QuantitativePrimary· 12 weeks
Feasibility of the Move physical activity support program will be assessed using the Perceived Characteristics of Intervention Scale (PCIS) collected only at the level of the provider. Scores range from 0 to 4, with higher scores indicating a better outcome.
Group
Value
95% CI
Coach
3.5
Sponsor's own description
The objective of this study is to design and refine an activity support program for overweight or obese adults called Move. The primary outcomes are feasibility and acceptability of the Move physical activity support program.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Other recruiting trials for Overweight and Obesity
Currently open trials in the same condition.
NCT06282952 — Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation
· NA
· recruiting
NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors
· NA
· recruiting
NCT07230496 — A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE103 or LAE103 in Combination With LAE102 in Healt
· Phase 1
· recruiting
NCT07313761 — A Trial to Compare the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered
· Phase 1
· active not recruiting
NCT07165431 — Effect of a Postbiotic Supplementation in Overweight and Obese Subjects: A Randomized Controlled Trial (PARABIOTICS-2).
· NA
· recruiting
Other University of Colorado, Denver trials
Trials by the same sponsor.
NCT07292285 — The Surveillance Nonoperative Watch & Wait (SNOWW) Rectal Cancer Trial.
· not yet recruiting
NCT07021937 — Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity
· Phase 3
· not yet recruiting
NCT07453732 — Banana Leaves as a Wound Dressing for Partial Thickness Second Degree Burns in Adult Patients.
· NA
· not yet recruiting
NCT07038278 — 5-AminoLevulinic Acid Aided Resection Margins in Sarcoma
· EARLY_PHASE1
· not yet recruiting
NCT07279558 — Cannabidiol and Alcohol Use Disorder Phenotypes
· Phase 2
· recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Colorado, Denver
Last refreshed: 10 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05865392.